A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Edirol, Generic Drugs All Now Face Supply Curbs as Nichi-Iko Woes Spill Over
July 8, 2021
-
BUSINESS Bristol Myers Kicks Off COVID-19 Inoculation Program, Eliminates Cost Burden on Employees
July 8, 2021
-
BUSINESS 26 Japan Drug Makers’ Annual Pay Averages 8.21 Million Yen, 5 Firms Top 10 Million Yen Mark
July 7, 2021
-
BUSINESS Astellas Revamping Sales Organization as Product Mix Shifts towards Specialty Area: CEO
July 6, 2021
-
BUSINESS Sagent Jettisons Camostat Mesilate for COVID-19 after PII Miss: Nichi-Iko
July 6, 2021
-
BUSINESS All Ranitidine Tablet Drugs to Be Discontinued in Japan over Carcinogen Woes
July 5, 2021
-
BUSINESS Ivermectin to Enter 1st Company-Sponsored COVID-19 Trial in Japan
July 2, 2021
-
BUSINESS 3 Major Wholesalers, 7 Employees Found Guilty in Bid-Rigging Trial
July 2, 2021
-
BUSINESS Ayumi to Leverage IT to Boost Sales and Marketing, Eyes More Licensing Deals
July 2, 2021
-
BUSINESS New BMS Japan Boots Up with Richer Cancer Assets as Celgene Merger Closes
July 1, 2021
-
BUSINESS 2 Ono Employees Found Guilty for Onoact Bribery Charges; Scholarship Donation in Spotlight
June 30, 2021
-
BUSINESS Chugai Files Regeneron’s Antibody Cocktail in Japan
June 30, 2021
-
BUSINESS Organon Japan to Focus on Women’s Health, Enrich Offerings with Global Products: President
June 29, 2021
-
BUSINESS MSD Chief Wants Japan to Eliminate Disincentives Tied to Re-Pricing Rules as Keytruda Faces Repeated Cuts
June 28, 2021
-
ACADEMIA Architect of Oncolytic Virus Therapy Looks to Its Use in All Solid Cancers in 5 Years
June 25, 2021
-
BUSINESS Japan Pharma Market Forecast to Decline through FY2025: IQVIA
June 25, 2021
-
ACADEMIA Reproductive Medicine Society Issues Fertility Treatment Guidelines, Prods Careful Design for Health Coverage
June 25, 2021
-
REGULATORY Japan Approves Verquvo, Evrysdi, 2 CGRP Migraine Meds and More
June 24, 2021
-
REGULATORY Japan to Stop Accepting Requests for Moderna Vaccines for Workplace Inoculations
June 24, 2021
-
BUSINESS MSD Tops Foreign Pharma List in Japan in FY2020, but Big Players in a Melee
June 23, 2021
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…